INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $10,000 | -33.3% | 19,250 | 0.0% | 0.01% | -28.6% |
| Q4 2017 | $15,000 | -46.4% | 19,250 | 0.0% | 0.01% | -46.2% |
| Q3 2017 | $28,000 | -46.2% | 19,250 | 0.0% | 0.01% | -50.0% |
| Q2 2017 | $52,000 | -3.7% | 19,250 | +45.3% | 0.03% | -3.7% |
| Q1 2017 | $54,000 | -3.6% | 13,250 | 0.0% | 0.03% | -6.9% |
| Q4 2016 | $56,000 | -37.8% | 13,250 | 0.0% | 0.03% | -35.6% |
| Q3 2016 | $90,000 | +16.9% | 13,250 | 0.0% | 0.04% | +15.4% |
| Q2 2016 | $77,000 | -16.3% | 13,250 | 0.0% | 0.04% | -20.4% |
| Q1 2016 | $92,000 | – | 13,250 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|